Sign in to view content

Avacincaptad Pegol, A Novel C5 Inhibitor, and GATHER1 Study: Results From a Post-Hoc Analysis of Nascent Geographic Atrophy

Peter K. Kaiser, MD FASRS

Video
Published 2021

Related

Therapeutic Horizons for Dry AMD
Robert L. Avery, MD
Updates from the Field
2019
First Time Results of VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy
Omer Trivizki, MD, MBA
Updates from the Field
2025
Episode 196: Dr. Sharon Fekrat on vitreretinal fellow education, alpha-melanocyte stimulating hormone and more
Jayanth Sridhar, MD
Member Podcasts
2019

Category: AMD-Non-Neovascular

See more